about
sameAs
Genome-wide association studies identify four ER negative-specific breast cancer risk lociGenome-wide association study identifies novel breast cancer susceptibility lociXRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control studyProstate cancer: ESMO Consensus Conference Guidelines 2012Penetrance analysis of the PALB2 c.1592delT founder mutation.Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish populationΓ-secretase components as predictors of breast cancer outcomePALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)Large-scale genotyping identifies 41 new loci associated with breast cancer risk.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expression.Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer.Transcription factors zeb1, twist and snai1 in breast carcinoma.Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data.Type II transmembrane serine protease gene variants associate with breast cancer.Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.The visibility of cancer on previous mammograms in retrospective review.The extent of linkage disequilibrium in four populations with distinct demographic histories.Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerSULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.Genetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumActivity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.MicroRNA related polymorphisms and breast cancer risk.Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
P50
Q24622610-725B0F0B-E0DA-41EE-9301-7F9F26BEA06CQ24645441-315512D3-D331-479B-BDD3-2CA5E6C99DEEQ25257811-EEB56D2E-9A34-4197-BC94-CF26BD461C53Q27022847-3982F57C-F5EA-4BE8-A6CB-9BCF299CA374Q27851443-91F3CFE4-5C71-45EE-ADFD-444A2ACEB5FFQ28301674-9D155E9B-545A-4785-8E08-537AD6B485BAQ28534781-0DCBF4A8-C4AB-46F6-A418-57714B9FF4E0Q28584533-EB710C9E-252E-4750-A9F6-2B6C151F383FQ29038654-FE978E87-7B1A-46E2-96F1-993DCF8B59D6Q29416989-4478286F-9CCA-4972-92AD-F046B39A0AD9Q30374367-FFFCBAEE-FB0A-4F77-A599-59DC93D36783Q30802558-720B68D3-B603-4F51-8935-98C7F269C11EQ30870035-BEE137B7-8B69-428E-BA62-70D80BD4FCFBQ31082788-920E8ADB-2C07-447E-AFFD-8C07FC6EAFF6Q33330850-6FB2D776-67F0-41A8-852C-D883CBBBBD28Q33801758-3CA1C91F-116C-4F6A-B31A-73740097FFF3Q33821467-1BBD4728-2278-40EC-9FAB-156A4486DBEDQ33828680-6438976A-EE75-419A-93C2-172C452AC425Q33848895-8E7537AA-6821-448C-A548-0A1349E6D649Q33910297-654EFD84-3912-4062-B6A9-C3C47150176CQ33910850-257DB687-346A-464D-BF0B-78103A5849E6Q34022779-65D29291-8B57-4558-BFFC-8B5B2D94B609Q34038964-6D988BFB-4A9F-4F16-A085-1942290E61ECQ34123806-C74B4F38-06F8-43B0-BF8A-D15E930788D2Q34132450-3F175345-6C1F-466C-A6AE-3ADC5C062DD4Q34144358-00B7179E-D422-423C-9E20-D0F7F4169A0FQ34181322-633B8C24-C56D-4964-9134-74AF48D28D24Q34307873-1F911705-AE32-4FF9-9B24-6DC45996659BQ34327945-852A3EFA-40BB-4CEF-83A1-A001AB9FF49DQ34351474-86655713-5D7E-45B9-B9DA-A635DE03785EQ34372081-F422729C-B592-487A-9882-BA18F17BEE27Q34378972-6CB29D75-E8F2-440D-83B0-874BFF062BDAQ34379032-6FE6D4FC-93B4-4653-BF75-795F42FC6C57Q34426881-A93E4E6E-9FE3-487E-B635-D652B00067BCQ34496969-5C34AB15-D4B6-4350-8E04-56099A73170AQ34497352-21F0F862-D5B8-45BB-B33E-5AB9058A3018Q34613673-FB69C57B-B059-4A55-A9C2-0A245D443F31Q34620634-C5D0999B-07A7-4DE4-824C-E317BD9F18E9Q34898735-DDB2F70D-4C86-45FE-BA46-42A0CDFC3158Q34903062-F34E894C-3F19-45FD-A06A-9F2844DFED9B
P50
description
Finnish researcher, chief phys ...... l Finland Health Care District
@en
Fins chef-arts
@nl
finnischer Professor und Chefarzt
@de
suomalainen tutkija, syöpätaut ...... nhoitopiirin johtajaylilääkäri
@fi
name
Vesa Kataja
@ast
Vesa Kataja
@ca
Vesa Kataja
@en
Vesa Kataja
@es
Vesa Kataja
@fi
Vesa Kataja
@fr
Vesa Kataja
@ga
Vesa Kataja
@nl
Vesa Kataja
@sl
Vesa Kataja
@sq
type
label
Vesa Kataja
@ast
Vesa Kataja
@ca
Vesa Kataja
@en
Vesa Kataja
@es
Vesa Kataja
@fi
Vesa Kataja
@fr
Vesa Kataja
@ga
Vesa Kataja
@nl
Vesa Kataja
@sl
Vesa Kataja
@sq
altLabel
V. Kataja
@en
Vesa V. Kataja
@en
prefLabel
Vesa Kataja
@ast
Vesa Kataja
@ca
Vesa Kataja
@en
Vesa Kataja
@es
Vesa Kataja
@fi
Vesa Kataja
@fr
Vesa Kataja
@ga
Vesa Kataja
@nl
Vesa Kataja
@sl
Vesa Kataja
@sq
P106
P21
P214
139148207879100341530
P27
P31
P496
0000-0003-4846-4843
P6634
vesa-kataja-4a19a794
P734
P735
P7859
viaf-139148207879100341530